Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Dec;7(Suppl 3):S246-S257.
doi: 10.21037/cdt.2017.09.18.

Anti-fouling strategies for central venous catheters

Affiliations
Review

Anti-fouling strategies for central venous catheters

Alex Wallace et al. Cardiovasc Diagn Ther. 2017 Dec.

Abstract

Central venous catheters (CVCs) are ubiquitous in the healthcare industry and carry two common complications, catheter related infections and occlusion, particularly by thrombus. Catheter-related bloodstream infections (CRBSI) are an important cause of nosocomial infections that increase patient morbidity, mortality, and hospital cost. Innovative design strategies for intravenous catheters can help reduce these preventable infections. Antimicrobial coatings can play a major role in preventing disease. These coatings can be divided into two major categories: drug eluting and non-drug eluting. Much of these catheter designs are targeted at preventing the formation of microbial biofilms that make treatment of CRBSI nearly impossible without removal of the intravenous device. Exciting developments in catheter impregnation with antibiotics as well as nanoscale surface design promise innovative changes in the way that physicians manage intravenous catheters. Occlusion of a catheter renders the catheter unusable and is often treated by tissue plasminogen activator administration or replacement of the line. Prevention of this complication requires a thorough understanding of the mechanisms of platelet aggregation, signaling and cross-linking. This article will look at the advances in biomaterial design specifically drug eluting, non-drug eluting, lubricious coatings and micropatterning as well as some of the characteristics of each as they relate to CVCs.

Keywords: Biofouling; catheters; central venous catheters (CVCs); infections; thrombosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Infectious fouling of catheters can occur by migration of bacteria from the surface of the catheter, from the lumen of the catheter and from hematogenous seeding. Biofilms protect the bacteria from mechanical motion and antibiotics. Prevention guidelines have been well established (13,14).
Figure 2
Figure 2
Demonstration of the one-way valve effect of incomplete occlusion by a fibrin sheath.
Figure 3
Figure 3
The major development steps of thrombosis on a surface. Protein adsorption to the surface causes a localized increase in concentration that promotes cellular adhesion. Cellular adhesion activates cascading effects to promote aggregation (35). Stabilization then occurs via fibrin cross-linking. Neutrophil extracellular traps may increase thrombotic events (36). Artificial surfaces can exacerbate portions of these steps (37,38).
Figure 4
Figure 4
Macroscopic image of a central venous catheter with an associated micro-CT image of a central venous catheter in a longitudinal, split and opened view. Note the smooth surface with eyelets near the end.
Figure 5
Figure 5
Slippery liquid-infused porous surfaces are a unique method of creating self-healing and protective surfaces by creating a porous surface and introducing a liquid with specific properties into the porous material (77-81). The material holds the liquid within the pores and as a thin layer on the surface to create highly protective surfaces.

Similar articles

Cited by

References

    1. Baskin JL, Pui CH, Reiss U, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009;374:159-69. 10.1016/S0140-6736(09)60220-8 - DOI - PMC - PubMed
    1. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for disease control and prevention. MMWR Recomm Rep 2002;51:1-29. - PubMed
    1. Rosenthal VD, Maki DG, Mehta Y, et al. International nosocomial infection control consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module. Am J Infect Control 2014;42:942-56. 10.1016/j.ajic.2014.05.029 - DOI - PubMed
    1. Harron K, Mok Q, Hughes D, et al. Generalisability and cost-impact of antibiotic-impregnated central venous catheters for reducing risk of bloodstream infection in paediatric intensive care units in England. PLoS One 2016;11:e0151348. 10.1371/journal.pone.0151348 - DOI - PMC - PubMed
    1. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81:1159-71. 10.4065/81.9.1159 - DOI - PubMed